NI201000131A - Tratamiento para trastornos relacionados con los ojos. - Google Patents
Tratamiento para trastornos relacionados con los ojos.Info
- Publication number
- NI201000131A NI201000131A NI201000131A NI201000131A NI201000131A NI 201000131 A NI201000131 A NI 201000131A NI 201000131 A NI201000131 A NI 201000131A NI 201000131 A NI201000131 A NI 201000131A NI 201000131 A NI201000131 A NI 201000131A
- Authority
- NI
- Nicaragua
- Prior art keywords
- treatment
- eye
- related disorders
- macular degeneration
- diabetic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3507308P | 2008-03-10 | 2008-03-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
NI201000131A true NI201000131A (es) | 2011-09-29 |
Family
ID=40583469
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NI201000131A NI201000131A (es) | 2008-03-10 | 2010-07-29 | Tratamiento para trastornos relacionados con los ojos. |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP2285378A1 (ru) |
JP (1) | JP2011513488A (ru) |
KR (1) | KR20110009084A (ru) |
CN (1) | CN101965188A (ru) |
AR (1) | AR070975A1 (ru) |
AU (1) | AU2009223501A1 (ru) |
BR (1) | BRPI0909659A2 (ru) |
CA (1) | CA2717991A1 (ru) |
CL (1) | CL2009000551A1 (ru) |
CO (1) | CO6290691A2 (ru) |
CR (1) | CR11644A (ru) |
DO (1) | DOP2010000266A (ru) |
IL (1) | IL207906A0 (ru) |
MA (1) | MA32211B1 (ru) |
MX (1) | MX2010008308A (ru) |
NI (1) | NI201000131A (ru) |
NZ (1) | NZ587906A (ru) |
RU (1) | RU2010141560A (ru) |
SV (1) | SV2010003658A (ru) |
TW (1) | TW200950784A (ru) |
WO (1) | WO2009114373A1 (ru) |
ZA (1) | ZA201005337B (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR074776A1 (es) | 2008-12-18 | 2011-02-09 | Sanofi Aventis | Metodo para tratar la degeneracion macular; modulando el sistema inmunitario del paciente |
EP2441755A1 (en) | 2010-09-30 | 2012-04-18 | Almirall, S.A. | Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors |
EP2489663A1 (en) | 2011-02-16 | 2012-08-22 | Almirall, S.A. | Compounds as syk kinase inhibitors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DZ3377A1 (fr) * | 1999-12-24 | 2001-07-05 | Aventis Pharma Ltd | Azaindoles |
JP2003523390A (ja) * | 2000-02-25 | 2003-08-05 | メルク エンド カムパニー インコーポレーテッド | チロシンキナーゼ阻害薬 |
US7563787B2 (en) * | 2005-09-30 | 2009-07-21 | Miikana Therapeutics, Inc. | Substituted pyrazole compounds |
CL2007002617A1 (es) * | 2006-09-11 | 2008-05-16 | Sanofi Aventis | Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto. |
-
2009
- 2009-03-05 NZ NZ587906A patent/NZ587906A/en not_active IP Right Cessation
- 2009-03-05 AU AU2009223501A patent/AU2009223501A1/en not_active Abandoned
- 2009-03-05 KR KR1020107019973A patent/KR20110009084A/ko not_active Application Discontinuation
- 2009-03-05 CA CA2717991A patent/CA2717991A1/en not_active Abandoned
- 2009-03-05 EP EP09718970A patent/EP2285378A1/en not_active Withdrawn
- 2009-03-05 WO PCT/US2009/036119 patent/WO2009114373A1/en active Application Filing
- 2009-03-05 RU RU2010141560/15A patent/RU2010141560A/ru unknown
- 2009-03-05 CN CN2009801075816A patent/CN101965188A/zh active Pending
- 2009-03-05 JP JP2010550758A patent/JP2011513488A/ja not_active Withdrawn
- 2009-03-05 MX MX2010008308A patent/MX2010008308A/es not_active Application Discontinuation
- 2009-03-05 BR BRPI0909659A patent/BRPI0909659A2/pt not_active IP Right Cessation
- 2009-03-09 AR ARP090100835A patent/AR070975A1/es not_active Application Discontinuation
- 2009-03-09 TW TW098107567A patent/TW200950784A/zh unknown
- 2009-03-09 CL CL2009000551A patent/CL2009000551A1/es unknown
-
2010
- 2010-07-27 ZA ZA2010/05337A patent/ZA201005337B/en unknown
- 2010-07-29 NI NI201000131A patent/NI201000131A/es unknown
- 2010-08-24 CR CR11644A patent/CR11644A/es not_active Application Discontinuation
- 2010-08-31 IL IL207906A patent/IL207906A0/en unknown
- 2010-09-01 CO CO10108103A patent/CO6290691A2/es not_active Application Discontinuation
- 2010-09-02 DO DO2010000266A patent/DOP2010000266A/es unknown
- 2010-09-07 SV SV2010003658A patent/SV2010003658A/es unknown
- 2010-10-06 MA MA33226A patent/MA32211B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
JP2011513488A (ja) | 2011-04-28 |
CA2717991A1 (en) | 2009-09-17 |
RU2010141560A (ru) | 2012-04-20 |
SV2010003658A (es) | 2011-01-31 |
CR11644A (es) | 2010-11-22 |
BRPI0909659A2 (pt) | 2015-09-22 |
WO2009114373A1 (en) | 2009-09-17 |
AR070975A1 (es) | 2010-05-19 |
CN101965188A (zh) | 2011-02-02 |
TW200950784A (en) | 2009-12-16 |
IL207906A0 (en) | 2010-12-30 |
NZ587906A (en) | 2011-12-22 |
AU2009223501A1 (en) | 2009-09-17 |
ZA201005337B (en) | 2011-04-28 |
MX2010008308A (es) | 2010-08-11 |
KR20110009084A (ko) | 2011-01-27 |
EP2285378A1 (en) | 2011-02-23 |
MA32211B1 (fr) | 2011-04-01 |
DOP2010000266A (es) | 2010-09-30 |
CO6290691A2 (es) | 2011-06-20 |
CL2009000551A1 (es) | 2009-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR120961A2 (es) | Método y composición para tratar hipertensión ocular y glaucoma | |
EA201590053A1 (ru) | Модуляторы пути системы комплемента и их применение | |
BR112014008759A8 (pt) | Tratamento de doença ocular | |
GT201300174A (es) | Compuestos de indol o análogos de los mismos útiles para el tratamiento de la degeneración macular relacionada con la edad (dme) | |
MX2015005831A (es) | Antagonistas de il-6 y usos de los mismos. | |
MY175318A (en) | Androgen composition for treating an opthalmic condition | |
CO6781507A2 (es) | Novedosos derivados heterociclicos | |
CU20120099A7 (es) | Derivados de pirazina y su uso en el tratamiento de trastornos neurológicos | |
ECSP11010974A (es) | Compuestos novedosos como ligandos receptores de canabinoides | |
GT201400131A (es) | Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina | |
NI201200016A (es) | Derivados de piridina y pirazina como moduladores de cinasa de proteína | |
ECSP089020A (es) | Compuestos novedosos como ligandos del receptor de canabinoides y usos de los mismos | |
UY33931A (es) | Agentes de union biespecificos | |
CR20140476A (es) | Agentes para tratar transtornos que implican la modulación de receptores de rianodina | |
DOP2014000033A (es) | Aminoquinazolinas como inhibidores de quinasa | |
EA201400338A1 (ru) | Производные аминопиримидина для применения в качестве модуляторов киназной активности | |
GT201500159A (es) | Derivados de imidazopiridazina como moduladores del receptor gabaa | |
EA201490721A1 (ru) | Лекарственное средство для лечения заболеваний передней камеры глаза, включающее ребамипид и агент, удерживающий слезы | |
CO6630193A2 (es) | Inhibidores de la actividad de la proteína tirosina quinasa seleccionada | |
ECSP11011485A (es) | Espiro-epóxidos como productos intermedios. | |
CL2015001187A1 (es) | Compuestos derivados de azaquinolin-carboxamida, como inhibidores de p70s6k; su metodo de manufactura; composicion farmaceutica que los comprende; y su uso para el tratamiento profilactico o terapeutico de trastornos hiperproliferativos, cancer, retinopatia diabetica, dolor, eczema y degeneracion macular relacionada con la edad, entre otras enfermedades. | |
DOP2013000304A (es) | Moduladores alostéricos positivos del receptor de acetilcolina nicotínico | |
GT201200216A (es) | Nuevos derivados terciarios de 8-hidroxiquinolina-7carboxamida y usos de los mismos. | |
ECSP13013016A (es) | Derivados de 2-amino-3-(imidazol-2-il)-piridin-4-ona, y su uso como inhibidores de la cinasa del receptor vegf | |
NI201000131A (es) | Tratamiento para trastornos relacionados con los ojos. |